US$ 28.16
allulose glp 1 agonist How Much to Trigger GLP-1: Dosage and Evidence Allulose in human diet: the
Description
These findings underscore the potential for GLP-1 RAs to offer tailored protection against complex diabetic complications, marking an advancement in personalized medicine for managing diabetes-acute kidney disease.

Allulose, a rare sugar, has been shown to stimulate GLP-1, reduce blood sugar spikes, and help control appetite without the side effects of medications

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.
